Mettler-Toledo/$MTD
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Mettler-Toledo
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.
- Ticker
- $MTD
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 16,600
- Headquarters
- Greifensee, Switzerland
- Website
- www.mt.com
Mettler-Toledo Metrics
BasicAdvanced
$35B
37.31
$46.15
1.17
-
Price and volume
Market cap
$35B
Beta
1.17
52-week high
$1,806.58
52-week low
$1,023.05
Average daily volume
201K
Financial strength
Current ratio
1.101
Quick ratio
0.628
Long term debt to equity
25.282
Total debt to equity
26.058
Interest coverage (TTM)
17.23%
Profitability
EBITDA (TTM)
1,245.195
Gross margin (TTM)
59.16%
Net profit margin (TTM)
22.25%
Operating margin (TTM)
27.63%
Effective tax rate (TTM)
17.22%
Revenue per employee (TTM)
$250,000
Management effectiveness
Return on assets (TTM)
20.09%
Return on equity (TTM)
-1,089.06%
Valuation
Price to earnings (TTM)
37.314
Price to revenue (TTM)
8.28
Price to book
442.71
Price to tangible book (TTM)
-37.5
Price to free cash flow (TTM)
39.933
Free cash flow yield (TTM)
2.50%
Free cash flow per share (TTM)
43.126
Growth
Revenue change (TTM)
6.51%
Earnings per share change (TTM)
15.09%
3-year revenue growth (CAGR)
2.39%
10-year revenue growth (CAGR)
5.44%
3-year earnings per share growth (CAGR)
5.53%
10-year earnings per share growth (CAGR)
13.04%
What the Analysts think about Mettler-Toledo
Analyst ratings (Buy, Hold, Sell) for Mettler-Toledo stock.
Analyst projections of the future price of Mettler-Toledo stock.
Bulls say / Bears say
Third-quarter sales rose 6% to $1.094 billion and adjusted EPS increased 13% to $12.57, with adjusted operating profit up 8%. That points to improving demand translating into stronger earnings. (Mettler-Toledo)
Growth was not limited to one product line: laboratory sales rose 6%, core industrial sales 5%, product inspection 8% and service revenue 7% in the third quarter. This breadth suggests demand across key end markets is recovering. (The Motley Fool)
Management raised its 2026 adjusted EPS outlook and expects 10% to 12% adjusted EPS growth in 2027, on about 5% sales growth. That outlook offers evidence of continued earnings momentum beyond the latest quarter. (Mettler-Toledo)
Mettler-Toledo’s premium valuation may leave little room for weaker growth: Redburn argued that mature markets and increasing competition could constrain pricing, while its earnings estimates sit below consensus. A valuation reset is a risk if growth falls short of expectations. (Investing.com)
Third-quarter local-currency growth was uneven: Asia/Rest of World rose 14%, compared with 3% in the Americas and 2% in Europe. Management expects tougher comparisons in China and remains cautious about Europe, so a slowdown in the strongest region could weigh on group growth. (Mettler-Toledo, The Motley Fool)
The company says changing tariffs and trade disputes create uncertainty and that further tariff changes could hurt results. It also warns that Middle East conflict and related economic effects could raise costs or affect customer decisions. (StockTitan)
Data summarised monthly by Lightyear AI. Last updated on 6 Nov 2026.
Mettler-Toledo Financial Performance
Revenues and expenses
Mettler-Toledo Earnings Performance
Company profitability
Upcoming events
No upcoming events
Mettler-Toledo News
AllArticlesVideos
Funds containing Mettler-Toledo
AllUSDEURGBP
Fund name | Fund size | $MTD weighting |
|---|---|---|
L&G Clean Water$GLUG | $772M | 2.26% |
L&G Clean Water£GLGG | $772M | 2.26% |
iShares MSCI World Health Care Sector Advanced€CBUF | $683M | 1.31% |
iShares MSCI World Health Care Sector Advanced£WHCA | $362M | 1.31% |
Invesco Health Care S&P US Select Sector$XLVS | $552M | 0.50% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.